Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Suvimol Niyomnaithama Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;b Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information

Zheng Quan Tohc Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;d Department of Pediatrics, The University of Melbourne, Parkville, Victoria, AustraliaView further author information

Patimaporn Wongprompitake Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information

Laddawan Jansarikitb Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandView further author information

Kanjana Srisutthisamphanf National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum thani, ThailandView further author information

Sompong Sapsutthipasg Department of Medical Sciences, Institute of Biological Products, Bangkok, ThailandView further author information

Yuparat Jantraphakornf National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science Development Agency (NSTDA), Pathum thani, ThailandView further author information

Natthakarn Mingngamsupg Department of Medical Sciences, Institute of Biological Products, Bangkok, ThailandView further author information

Paul V Licciardic Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia;d Department of Pediatrics, The University of Melbourne, Parkville, Victoria, AustraliaView further author information

Kulkanya Chokephaibulkita Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;h Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]

https://orcid.org/0000-0002-0140-4600 View further author information

show all

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date